Vanda Pharmaceuticals | VNDA - Market Capitalization


Vanda Pharmaceuticals reported $215.2M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 24.93B 1.82B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Novartis USD 328.21B 54.92B Nov/2026
Pfizer USD 169.88B 6.47B Nov/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Takeda JPY 9.26T 1.06T Sep/2026
Teva Pharmaceutical Industries USD 152.12B 105.39B Nov/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Veracyte USD 4.12B 414M Nov/2026